Michael G. Brattain

Heterogeneity of malignant cells from a human colonic carcinoma.

Michael G. Brattain, W D Fine, Fadl Khaled et al. · PubMed · 1981 · 484 citations

Medicine, Cell Biology, Oncology +10

Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines.

Isabelle Chantret, Alain Barbat, E Dussaulx et al. · PubMed · 1988 · 450 citations

Life Sciences, Cell Biology, Oncology +8

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

William M. Grady, Lois L. Myeroff, Sandra E. Swinler et al. · PubMed · 1999 · 392 citations

Life Sciences, Genetics, Oncology +15

Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells

Jing Wang, Lu‐Zhe Sun, Lois L. Myeroff et al. · Journal of Biological Chemistry · 1995 · 339 citations · Full text

Medicine, Genetics, Oncology +16

Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.

Shazli N. Malik, Michael G. Brattain, P. Ghosh et al. · PubMed · 2002 · 322 citations

Medicine, Oncology, Pathology +17